Claris Biotherapeutics headquarters details
- City
- Jersey City
- State / region
- New Jersey
- ZIP / postal code
- 07304
- Country
- United States
- Phone
- +1 201 344 7638
- Founded
- 2018
- Website
- clarisbio.com
Location map
Open in Google MapsAll Claris Biotherapeutics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Jersey City HQ | New Jersey | United States | Headquarters |
Showing the headquarters of 2 recorded locations. See every location in GraphIQ →
About Claris Biotherapeutics
Claris Biotherapeutics is headquartered in Jersey City, New Jersey, United States. Founded in 2018, the company has 2 recorded locations and employs approximately 5 people worldwide.
Where is Claris Biotherapeutics's main office?
Claris Biotherapeutics's main headquarters office is located at Jersey City, New Jersey 07304, United States. This is the company's primary corporate address.
Claris Biotherapeutics contact information
The main switchboard for Claris Biotherapeutics headquarters can be reached at +1 201 344 7638. Official website: clarisbio.com.
What does Claris Biotherapeutics do?
Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.
Frequently asked questions
Where is Claris Biotherapeutics headquarters?
Claris Biotherapeutics's headquarters is located at Jersey City, New Jersey 07304, United States.
How many offices does Claris Biotherapeutics have?
GraphIQ records 2 locations for Claris Biotherapeutics, as of October 2026.
When was Claris Biotherapeutics founded?
Claris Biotherapeutics was founded in 2018 and employs approximately 5 people.
What is Claris Biotherapeutics's phone number?
The main phone number for Claris Biotherapeutics headquarters is +1 201 344 7638.
How many employees does Claris Biotherapeutics have?
Claris Biotherapeutics has approximately 5 employees (GraphIQ estimate, 2026).